 |

Adjuvant Partners is a commercial strategy and business development consulting firm focused on biotech, pharmaceutical and medical device markets. Essentially,
our clients are established and emerging companies driven to achieve key business imperatives. Whether these imperatives are related to product development, portfolio
expansion, licensing, market development or growth through acquisition, we assist our clients in creating the process and relationships to achieve these outcomes faster.
Drug development is a collaborative process involving input and unique contributions from numerous talented scientists, technicians, and strategists throughout the development
process. Indeed, within the last 10 years the pharmaceutical, biotech, and device industries have come to appreciate that it is virtually impossible for any firm to retain the
necessary expertise in all facets of product development to meet their productivity goals alone. Through partnerships companies extend their pipelines, access new market
opportunities, improve clinical and regulatory prospects, and enhance in-house programs. These activities are essential to maximizing commercialization opportunities
and driving shareholder value. Partnerships and outsourcing are now a hallmark of the industry and most industry experts expect the steady growth in collaborations and
dealmaking to continue for the foreseeable future.
It is this essential activity of every drug and device company that is the focus of our work. We have dedicated our careers to understanding and perfecting the partnering
process. In doing so, we have built an industry network that is second to none and strategic, proprietary search and evaluation tools that are designed to support the work
of business development professionals in all sectors of the industry. We use these tools and expertise to provide sound strategic, financial, and operational advisory
services to a range of customers from small, emerging companies to established multinational pharma and device companies. Our mission is to deliver specialized
knowledge to optimize the business development and strategic transaction process to accelerate value creation for our clients. There is no mass market in transaction
advisory services - we sustain our business through trusted relationships and performance, one client and one engagement at a time.
We invite you to learn how Adjuvant Partners can improve your business. We strive to maximize opportunity and value for our clients and their shareholders. Contact
us by emailing Morrie Ruffin at mruffin@adjuvant.com or by calling us at (301) 761-4522.

|
 |